The OT’s and PT’s Role in Treating Patients with Neurodegenerative Diseases

More than 6 million Americans suffer from neurodegenerative diseases including Parkinson’s Disease, Multiple Sclerosis, ALS, and Huntington’s Disease. Medical treatment options for these diseases are improving – but medication is only a piece of the treatment puzzle. Occupational and physical therapy are instrumental in helping patients live with new and often worsening impairments and addressing how these diseases impact daily life.

ERI Faculty Member Bobby Hand, DPT, MSCS, NCS, PT is a board-certified clinical specialist in neurologic physical therapy and serves as Movement Disorder Program Coordinator at VCU Parkinson’s and Movement Disorders Center.  Bobby’s passion is treating individuals with neurological disorders through compassionate therapeutic care and developing, implementing and sharing innovative, evidence-based therapeutic treatments with fellow therapists. In fact, Bobby recently spoke at The Parkinson Foundation’s Allied Team Training for Parkinson’s (ATTP®) about serving on a team of specialists and developing programs for patients.

Bobby is now sharing his expertise with PTs and OTs through his course, “Rehabilitative Management of Patients with Parkinson’s Disease and Other Neurodegenerative Diseases,” taking place March 14-15, 2020 at South Shore Hospital in Weymouth, Massachusetts. The course will teach evidence-based methods to treat neurodegenerative diseases and include goal writing, adaptive devices, balance training, wheelchair recommendations, energy conservation techniques, fall prevention strategies, and strength and mobility training as well as how to effectively plan for what the future holds.

Rehabilitation professionals play a crucial role in treating those suffering from neurodegenerative diseases. Learn how you can improve your practice and help patients address unique challenges in mobility and daily activities. Register for “Rehabilitative Management of Patients with Parkinson’s Disease and other Neurodegenerative Diseases.”